Revenue

A new partnership will supply Japan's surging cell therapy sector with critical, GMP-grade materials, aiming to accelerate the path from lab to clinic.

Ramsay Health Care will distribute its 52.79% stake in its European arm, setting the stage for a new era of autonomy and strategic focus for the group.

Ghana ratifies a major oil deal with Kosmos Energy until 2040, promising $2B in investment but raising questions about long-term financial and green goals.

Swedish consulting firm BTS Group reports a sharp drop in 2025 profits but bets on a new North American strategy and AI to fuel a 2026 comeback.

Global distributor IMCD deepens its food and nutrition footprint with the strategic acquisition of Willows Ingredients, targeting high-growth niche markets.

A drop in 2025 revenue hides Orano's strong operational health, reduced debt, and major strategic wins, including a key US uranium enrichment project.

A new all-inclusive package at Haneda Airport offers kimonos and fine dining, transforming the layover into a curated cultural journey for elite travelers.

UST's top partner award from TestMu AI highlights a new era of AI-driven testing, promising faster, more reliable software for global enterprises.

The CEO Magazine launches a platform to curate trusted businesses for the elite, but its model raises questions about the line between endorsement and advertising.

Despite a stock dip, Select Water Solutions' major offering signals a strategic push for growth in water recycling, acquisitions, and infrastructure.

With a 20% dividend hike, BayCom (BCML) rewards shareholders. We dive into the financials and what this means for investors and the banking sector.

A landmark agreement sees Tla’amin Nation acquire a massive forest tenure, blending traditional stewardship with a new model for BC's forestry industry.

The HVAC giant reports a monumental year, doubling earnings and its project backlog, signaling a major boom in the data center and industrial sectors.

Seagate retires $600M in debt for cash and stock. A strategic move to fortify its balance sheet, but what does the share dilution mean for investors?

The iBuying giant reports faster sales and record margins for new home buys, signaling its turnaround plan may finally be taking hold.

A federal court ruling against Corcept Therapeutics clears a key legal hurdle for Teva's generic Cushing's syndrome drug, rattling investors.

Travere Therapeutics reports a profitable Q4 driven by its kidney drug FILSPARI, but a revenue miss and a critical FDA decision create a complex outlook.

The smart property leader surpasses a major revenue milestone, driven by AI-powered security and energy management, but a mixed 2026 forecast follows.

St. Joe's new sales center combines real estate, title, and insurance to streamline homebuying as Bay County's population and property market surges.

Five9 reports a record $1.1B year and a return to profitability, as its new CEO bets big on AI to reshape the customer experience market.